Publications for Annika Håkansson
Co-author map based on ISI articles 2007-
Journal Articles
Birgitta Clinchy, Annelie Fransson, Pelle Druvefors, Anna Hellsten, Annika Håkansson, Bertil Gustafsson, Rune Sjödahl and Leif Håkansson
Preoperative interleukin-6 production by mononuclear blood cells predicts survival after radical surgery for colorectal carcinoma
Cancer, 2007, 109(9), 1742-1749.
Web of Science® Times Cited: 11 |
Bertil Kågedal, Malin Farnebäck, Annika Håkansson, Bertil Gustafsson and Leif Håkansson
How useful are housekeeping genes?: variable expression in melanoma metastases
Clinical Chemistry and Laboratory Medicine, 2007, 45(11), 1481-1487.
Web of Science® Times Cited: 4 |
Birgitta Clinchy, Marie Gunnerås, Annika Håkansson and Leif Håkansson
Production of IL-1Ra by human mononuclear blood cells in vitro: Influence of serum factors
Cytokine, 2006, 34( 5-6), 320-330.
Web of Science® Times Cited: 3 |
Jana M Schüle, Leif Bergkvist, Leif Håkansson, Bertil Gustafsson and Annika Håkansson
CD28 expression in sentinel node biopsies from breast cancer patients in comparison with CD3-ζ chain expression
Journal of Translational Medicine, 2004, 2, .
|
Annika Håkansson, Leif Håkansson, Bertil Gustafsson and Bertil Kågedal
Bcl-2 monitoring in malignant melanoma
Hospital Pharmacy, 2004, , 46-47.
|
Annika Håkansson, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, Björn Rettrup, Dirk Ruiter and Monique R Bernsen
On the effect of biochemotherapy in metastatic malignant melanoma: An immunopathological evaluation
Melanoma research, 2003, 13(4), 401-407.
Web of Science® Times Cited: 5 |
Monique R Bernsen, Toon Smetsers, Els van der Westerlo, Dirk Ruiter, Leif Håkansson, Bertil Gustafsson, Toin van Kuppevelt, Lennart Krysander, Björn Rettrup and Annika Håkansson
Heparan sulphate epitope-expression is associated with the inflammatory response in metastatic malignant melanoma
Cancer Immunology and Immunotherapy, 2003, 52(12), 780-783.
Web of Science® Times Cited: 3 |
MR Bernsen, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, B Rettrup, D Ruiter and Annika Håkansson
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
British Journal of Cancer, 2003, 88(3), 424-431.
Web of Science® Times Cited: 23 |
Annika Håkansson, Bertil Gustafsson, Avni Abdiu, Lennart Krysander and Leif Håkansson
Bcl-2 expression in metastatic malignant melanoma. Importance for the therapeutic efficacy of biochemotherapy
Cancer Immunology and Immunotherapy, 2003, 52(4), 249-254.
Web of Science® Times Cited: 9 |
Jana Schüle, Leif Bergkvist, Leif Håkansson, Bertil Gustafsson and Annika Håkansson
Down-regulation of the CD3-? chain in sentinel node biopsies from breast cancer patients
Breast Cancer Research and Treatment, 2002, 74(1), 33-40.
Web of Science® Times Cited: 22 |
Annika Håkansson, Leif Håkansson, Bertil Gustafsson, Lennart Krysander, Björn Rettrup, Dirk Ruiter and Monique Bernsen
Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28
Cancer Immunology and Immunotherapy, 2002, 51(9), 499-504.
Web of Science® Times Cited: 11 |
L Carlsson, Annika Håkansson and Bo Nordenskjöld
Common cancer-related symptoms among GP patients - Opportunistic screening in primary health care
Scandinavian Journal of Primary Health Care, 2001, 19(3), 199-203.
Web of Science® Times Cited: 7 |
Annika Håkansson, Bertil Gustafsson, Lennart Krysander, B Hjelmqvist, B Rettrup and L Håkansson
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes
British Journal of Cancer, 2001, 85(12), 1871-1877.
Web of Science® Times Cited: 20 |
Malin Johansson, Kerstin Årstrand, Annika Håkansson, C Lindholm and Bertil Kågedal
Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction
Melanoma research, 2000, 10(3), 213-222.
Web of Science® Times Cited: 10 |
Annika Håkansson, Bertil Gustafsson, Lennart Krysander, Bengt Hjelmqvist, Björn Rettrup and Leif Håkansson
On down-regulation of the immune response to metastatic malignant melanoma.
Cancer Immunology and Immunotherapy, 1999, 48, 253-262.
|
Annika Håkansson, Bertil Gustafsson, Lennart Krysander, B. Hjelmqvist, B. Rettrup and L. Håkansson
Expression of ICAM-1 during IFN-alpha-based treatment of metastatic malignant melanoma: relation to tumour infiltrating mononuclear cells and regressive tumour changes.
Journal of Interferon and Cytokine Research, 1999, 19, 171-177.
|
Ph.D. Theses
Ph.D., Lic. Theses
